Go to Wolters Kluwer VitalLaw.comGo to Wolters Kluwer VitalLaw.com
VitalLaw®
  • Find answers to your questions
  • Log in to access your subscriptions
In depth. On point.
In depth. On point.
  • Home
  • Legal Directory
  • Home
  • Legal Directory
In depth. On point.
  • Articles
  • Articles
  • Law Firms
  • Law Firms
  • Organizations
  • Organizations
    • FRAUD AND ABUSE—7th Cir.: Juror’s ‘research’ did not have a prejudicial effect on the verdict; the trial evidence supported use of the ‘ostrich’ instruction
    • CONTROLLED SUBSTANCES—FINAL RULES: DEA moves to ban four emerging synthetic opioids
    • DRUGS AND BIOLOGICS—FINAL RULES: DEA places newly approved anesthetic Cipepofol in Schedlue IV
    • DRUGS AND BIOLOGICS—NOTICES: FDA extends review of estrogen-androgen drug decision
    • EXPERT INSIGHTS—CMS Gains Exclusion Authority: What Healthcare Providers Should Be Watching
    • HEALTH CARE REFORM—OTHER AGENCY DOCUMENTS: Agencies ease retroactive-reward rule for wellness programs
    • PRESCRIPTION DRUGS—7th Cir.: Seventh Circuit upholds Arkansas pharmacy payment and reporting rule against ERISA challenge
    • REGULATION TRACKER—Information on pending or recently adopted regulations and regulation amendments
    • WORTH NOTING—Other Health Law litigation and regulatory developments
  • Articles
  • Articles
  • Law Firms
  • Law Firms
  • Organizations
  • Organizations

    Health Law Daily Wrap Up, EXPERT INSIGHTS—CMS Gains Exclusion Authority: What Healthcare Providers Should Be Watching, (Aug 31, 2026)

    Law Firms Mentioned:Holland & Knight
    Organizations Mentioned:Centers for Medicare & Medicaid Services | Holland & Knight, LLP | U.S. Department of Justice

    By Scott O'Connell of Holland & Knight

    A recent announcement from U.S. Department of Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. signals the possibility of a significant shift in federal healthcare program enforcement. While much of the attention has focused on the Tru ...

    By Scott O'Connell of Holland & Knight

    A recent announcement from U.S. Department of Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. signals the possibility of a significant shift in federal healthcare program enforcement. While much of the attention has focused on the Trump Administration's efforts to address Medicaid fraud, a potentially more consequential development is the decision to allow the Centers for Medicare & Medicaid Services (CMS) to exercise exclusion authority alongside the HHS Office of Inspector General (OIG).

    Historically, the OIG in conjunction with the U.S. Department of Justice has been responsible for excluding individuals and entities from participation in Medicare and Medicaid following certain fraud, abuse, patient safety or controlled substance-related violations. Exclusion can be one of the most severe enforcement actions available to the government, as it can effectively prevent providers from participating in federally funded healthcare programs individually and through future-formed corporate entities or employment opportunities.

    Although details of the delegation have not yet been released publicly, healthcare industry observers expect the change could expand the government's enforcement capacity and increase the number of exclusion actions pursued. Questions remain regarding how CMS and OIG will divide responsibilities, whether CMS will focus on certain categories of cases and how this authority will interact with CMS' existing powers, including Medicare enrollment revocations.

    For healthcare providers–particularly organizations with significant Medicare or Medicaid participation–the announcement serves as an important reminder to evaluate compliance programs, fraud and abuse controls, and risk assessment processes. Until additional guidance is issued, providers should monitor developments closely and prepare for the possibility of heightened enforcement activity.

    Scott O'Connell

    Holland & Knight

    10 St. James Avenue,

    11th Floor, BostonMA 02116,

    United States

    Tel.: +1 617 5232700

    E-mail: webcontent@hklaw.com

    URL: www.hklaw.com/

    (c) Mondaq Ltd, 2026 - Tel. +44 (0)20 8544 8300 - http://www.mondaq.com

    Attorneys: Scott O'Connell (Holland & Knight).

    ExpertInsights: NewsStory ExpertInsights CMSNews CoPNews EnforcementNews FraudNews QualityNews

    © 2026 CCH Incorporated and its affiliates and licensors. All rights reserved.

    • Manage Cookie Preferences
    • Privacy Statement
    • Terms of Use